Femasys appoints Nantahala-designated director after Pointillist's board right ends
John Moorhead joins Femasys's board as a designee of Nantahala Capital Management, replacing Kenneth Eichenbaum, whose seat was tied to a since-terminated nomination right held by Pointillist Global Macro Series.
Femasys Inc. (NASDAQ: FEMY) announced on October 30, 2026 that the Board appointed John Moorhead as a director of the Company, effective as of that date.1 The appointment followed the resignation of Kenneth D. Eichenbaum, who informed the Board of Directors of Femasys Inc. of his resignation as a director of the Company, effective as of that date.1
The filing specifies that Dr. Eichenbaum's resignation was in connection with Pointillist Global Macro Series of Pointillist Partners LLC's termination of its right to nominate an individual to serve on the Board pursuant to that certain Securities Purchase Agreement, dated November 3, 2025, by and among the Company and certain accredited investors.1 The company added that Dr. Eichenbaum's decision to resign was not due to any dispute or disagreement with the Company, or on any matter relating to the Company's operations, policies or practices.1
Moorhead's seat comes through a separate arrangement: he was appointed to the Board pursuant to the board designation rights granted to Nantahala Capital Management, LLC under the side letter agreement, dated as of August 7, 2026, between the Company and the Lead Investor, pursuant to which the Company agreed to appoint up to two individuals designated by the Lead Investor to serve on the Board.1 That right is subject to certain minimum ownership thresholds of the Company's outstanding common stock set forth in the Side Letter.1
Femasys said Moorhead will hold office as a Class II director for a term expiring at the 2029 annual meeting, at which time he will stand for election by the stockholders of the Company, and the Board determined that he is an independent director for purposes of the Nasdaq listing requirements and will serve on the Audit Committee and Compensation Committee.1
Moorhead's background includes 12 years at Unilever's Seventh Generation, rising from Associate Brand Manager to Chief Marketing Officer, and most recently serving as Head of Marketing, North America, at SBM Life Science, leading the BioAdvanced and Natria lawn and garden brands.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.